Boardroom Alpha
Boardroom Alpha
ATLX · Current Report (Form 8-K) · Filed December 12, 2025

Atlas Lithium Corp — Current Report (Form 8-K)

Form
8-K
Filed
December 12, 2025
Period
Dec 12, 2025
Ticker
ATLX
Accession
0001493152-25-027508
Boardroom Alpha · Filing insights

Atlas Lithium expands its ATM program with a prospectus supplement to offer up to $40 million of common stock through H.C. Wainwright.

About Atlas Lithium Corp
Market cap
$104M
1Y TSR
−45.5%
3Y TSR
−50.7%
Board grade
D
Sector
Basic Materials
CEO
Marc Fogassa
Last annual meeting: May 28, 2026 · View full Atlas Lithium Corp profile →

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): December 12, 2025

 

ATLAS LITHIUM CORPORATION

(Exact name of registrant as specified in its charter)

 

Nevada   001-41552   39-2078861

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

 

Rua Antonio de Albuquerque, 156 - 17th Floor

Belo Horizonte, Minas Gerais, Brazil, 30.112-010

(Address of principal executive offices, including zip code)

 

(833) 661-7900

(Registrant’s telephone number, including area code)

 

Not applicable

(Former address if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbol(s)   Name of Each Exchange on Which Registered
Common Stock, $0.001 par value   ATLX   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 8.01. Other Events.

 

As previously disclosed, Atlas Lithium Corporation (the “Company”) entered into that certain At The Market Offering Agreement, dated November 22, 2024 (the “Agreement”) with H.C. Wainwright & Co., LLC, as sales agent (“Wainwright”) with respect to an at the market offering program (the “ATM Program”), under which the Company may, from time to time in its sole discretion, issue and sell through Wainwright, acting as agent, shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”).

 

On December 12, 2025, the Company filed a prospectus supplement (the “Prospectus Supplement”) with the Securities and Exchange Commission (the “SEC”) pursuant to Rule 424(b) promulgated under the Securities Act of 1933, as amended, under the Company’s existing shelf registration statement on Form S-3 (File No. 333-289905) filed by the Company with the SEC on August 22, 2025, which became effective on September 3, 2025 (the “Registration Statement”), including the base prospectus contained therein, dated August 22, 2025, forming part of the Registration Statement. The Prospectus Supplement relates to the offer and sale from time to time by the Company, at its sole discretion, through Wainwright as part of the ATM Program, additional shares of Common Stock having an aggregate offering price of up to $40,000,000 (the “Shares”).

 

The legal opinion of Brownstein Hyatt Farber Schreck, LLP as to the legality of the Shares under Nevada law is being filed as Exhibit 5.1 to this Current Report on Form 8-K.

 

This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy the securities discussed herein, nor shall there be any offer, solicitation or sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

 

Item 9.01. Financial Statements and Exhibits.

 

Exhibit

No.

  Description
5.1   Opinion of Brownstein Hyatt Farber Schreck, LLP
23.1   Consent of Brownstein Hyatt Farber Schreck, LLP (included in Exhibit 5.1)
104   Cover Page Interactive Data File (embedded with the Inline XRBL document)

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ATLAS LITHIUM CORPORATION
     
Dated: December 12, 2025 By: /s/ Marc Fogassa
  Name: Marc Fogassa
  Title: Chief Executive Officer

 

 

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Atlas Lithium Corp (ATLX)

Reference

Frequently asked questions

When did Atlas Lithium Corp file this 8-K?
Atlas Lithium Corp (ATLX) filed this Current Report (Form 8-K) with the SEC on December 12, 2025. The accession number assigned by EDGAR is 0001493152-25-027508.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Atlas Lithium expands its ATM program with a prospectus supplement to offer up to $40 million of common stock through H.C. Wainwright. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Atlas Lithium Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Atlas Lithium Corp has filed under CIK 1540684, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer